<DOC>
	<DOCNO>NCT00757926</DOCNO>
	<brief_summary>A randomized , double-blind , placebo-controlled , staged dosage escalation study evaluate safety , tolerability , immunogenicity 3-dose series Live Attenuated Tetravalent ( G1-G4 ) Bovine-Human Reassortant Rotavirus Vaccine [ BRV-TV ] administer healthy Indian infant concurrently standard EPI vaccine would undertake evaluate study hypothesis 3-dose series BRV-TV ( contain VP7 serotypes G1 , G2 , G3 , G4 ) administer orally healthy Indian infant 6-8 , 10-12 , 14-16 week age concurrently standard EPI vaccine would generally well tolerate immunogenic .</brief_summary>
	<brief_title>Safety Immunogenicity Study Recombinant Human Bovine Reassortant Rotavirus Vaccine Healthy Indian Infants</brief_title>
	<detailed_description />
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy infant 68 week age either sex ; Born gestational period 3642 week birth weight &gt; 2 kg ; Father , mother legally acceptable representative ( guardian ) properly inform study sign informed consent form ( ICF ) ; Parent guardian available entire period study reachable study staff postvaccination followup . History congenital abdominal disorder , intussusception , abdominal surgery ; Known suspect impairment immunological function ; Known hypersensitivity component rotavirus vaccine ; Prior receipt rotavirus vaccine ; Fever , oral temperature ≥38.1oC ( ≥100.5oF ) ; presumably measure study staff ? History know rotavirus disease , chronic diarrhea , failure thrive ; Baseline level ALT AST &gt; 2.5 time upper limit normal ; Clinical evidence active gastrointestinal illness ( infant GERD participate study long condition well control without medication ) ; Receipt IM , oral , IV corticosteroid treatment ( infant inhale steroid may permit participate study ) ; Infants reside household immunocompromised person ( e.g. , individual congenital immunodeficiency , HIV infection , leukemia , lymphoma , Hodgkin 's disease , multiple myeloma , generalized malignancy , chronic renal failure , nephrotic syndrome , organ bone marrow transplantation , receive immunosuppressive chemotherapy include longterm systemic corticosteroid ) ; Infants test positive HBV , HCV , HIV infection ; Prior receipt blood transfusion blood product , include immunoglobulin ; Any infant adequately follow safety telephone and/or home visit ; Any condition , opinion investigator , might interfere evaluation study objective .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>8 Weeks</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>